Peng Zhan

机构：King University, University of Science and Culture, Shandong University of Traditional Chinese Medicine, Shandong University, Peking University, State Administration of Traditional Chinese Medicine of the People's Republic of China, Innovative Medicines Initiative, Tianjin Institute of Pharmaceutical Research (China), Ministry of Education · ORCID：0000-0002-9675-6026

发表论文 369 篇 · 总被引 10265 次 · h-index 52

代表论文

• Geologic hydrogen: From natural occurrences to anthropogenic generation – A review of fundamentals, potential, challenges and prospects (2025 · Earth-Science Reviews · 被引 11)
• Conquering viral drug resistance: Structural and mechanistic paradigms for antiresistance drug design (2025 · Pharmaceutical Science Advances · 被引 6)
• Differential inhibition of Morbillivirus and Henipavirus polymerases by ERDRP-0519 and structure-guided inhibitor optimization (2026 · Cell · 被引 3)
• A Novel Pyrrole Acylsulfonamide, Compound 42 , as a Dual URAT1/GLUT9 Inhibitor: Potent Urate-Lowering Efficacy, Reduced Off-Target Effects, and Promising Druggability for Hyperuricemia (2026 · Journal of Medicinal Chemistry · 被引 2)
• Design, Synthesis,and Biological Evaluation of HighlyPotent Boronic Acid (Boronate Ester)-Bearing HeteroaryldihydropyrimidineDerivatives as HBV Capsid Assembly Modulators (2025 · Journal of Medicinal Chemistry · 被引 2)
• Therapeutic approaches to addressing drug resistance by targeting membranes and associated structures (2025 · Drug Discovery Today · 被引 2)